Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. - Wikidata - awgldk - TriplyDB

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q46442389

about

OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data Development of onabotulinumtoxinA for chronic migraine Orofacial pain management: current perspectives.Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.The efficacy of botulinum toxin in patients with cervicogenic headache: a placebo-controlled clinical trial A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.Chronic migraine--classification, characteristics and treatment.Therapeutic use of botulinum toxin in migraine: mechanisms of action.Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine The prophylactic treatment of chronic daily headache.Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.Botulinum toxin type-A therapy in cluster headache: an open study.Botulinum toxin type a for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks.The importance of placebo in headache research.Chronic migraine plus medication overuse headache: two entities or not?Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.The use of botulinum neurotoxin type A (Botox) for headaches: a case review.OnabotulinumtoxinA for chronic migraine: a critical appraisal.An electronic diary on a palm device for headache monitoring: a preliminary experience.Botulinum toxin: could it be an effective treatment for chronic tension-type headache?The long-term efficacy and safety of botulinum toxin in refractory chronic tension-type headache Treatment of headaches with botulinum toxin.Botulinum toxin type A for the treatment of migraine.Migraine: emerging treatment options for preventive and acute attack therapy.Investigating prophylactic botulinum toxin type A for chronic headache disorders.Evidence-based understanding of medication-overuse headache: clinical implications.Botulinum toxin type A in chronic migraine.Current migraine management - patient acceptability and future approaches.Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache.OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine.Migraine treatment and placebo effect.Botulinum Toxin in Migraine Treatment.Botulinum toxin in the management of chronic migraine: clinical evidence and experience.Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse?Treatment of refractory pain with botulinum toxins--an evidence-based review.Botulinum toxin and the treatment of headache: a clinical review.OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.Emerging treatment for chronic migraine and refractory chronic migraine.OnabotulinumtoxinA for the treatment of headache.

P2860

Q26796286-1415EDF6-7943-42B1-983D-C484F02F9FF8 Q27027006-3EEAB0BE-5FEE-4964-A004-D6BA4AF5407E Q30442178-F2DAA961-B054-44D6-AF83-6E3CEF4859BE Q33475067-D3F9B7C8-4587-4E7D-B69C-4DBBB530ECA5 Q33973655-9FA3E95E-3366-4CB8-AAD7-22DF07932AD7 Q34003508-FFCE4EA1-CE40-4ECA-9755-4C8C10E44B39 Q34030691-F35CF312-C929-417B-A3A3-B3D471BBF3E6 Q34419654-51C24665-1264-4C72-876D-5402CE0CC128 Q34521929-99AFA81F-AC1A-4CB1-8BE7-0CAF3D464F10 Q34583067-7F9F7E2F-549A-4F32-9CFA-3C2A2EDC6C5B Q34593652-93376A84-08BD-41FE-AFAA-7A44A91734CC Q34694975-0EA03E3F-EF2B-42E9-B30F-3F0883CA1DE3 Q34760355-F4CF3489-EB80-48C7-A97D-F499A1EFE896 Q34770862-FB92A085-70E2-405E-A5E3-E367282F4380 Q34813721-D63D8F7C-46A2-4DBD-AF91-08AE25492328 Q35522746-F88B8A07-54F7-496E-82C1-8EB7ADF3D82D Q35681903-0E99639D-156D-41F0-8F06-8C6BC5479FA6 Q35729516-843C0ADB-BFAC-4A7A-B7C4-1DFA6282265A Q35822040-5B68B98F-3774-4A23-812F-62B98F8ABC8E Q36240282-4044667F-F2D2-4D6B-B6FC-63DCE3E2488B Q36259831-084EEFB6-9909-4E93-9E83-61644F5D5DC4 Q36332480-B2E872ED-38DE-499F-9D6A-D7FAC9E9B221 Q36419558-305F63DC-E4D6-4551-A5B1-9B3C95CE426B Q36488226-6A3CBBE8-CD6F-4A11-8DFE-6EA3DB5BF514 Q36580576-95595A14-5D36-4F75-B01D-EAF4B3D38517 Q36600278-193B0857-FCF5-48C7-AF92-82572559C1C3 Q36641577-2DF6AD82-8845-46F0-A529-4242C422AE15 Q36817036-982264F2-1E60-40EF-B642-DBBAE01C21D2 Q37106936-34FCFCB6-E6B7-47D6-B0C1-DCFD60A599EB Q37418971-E0269028-4161-4925-9B82-AB734F3339D9 Q37678415-02D1F011-7DA1-441F-A90D-AE88A9419BEA Q37699425-73A82912-1D77-48CA-9B38-1E5FA56A003B Q37703847-E6C4B5D7-8409-4DBF-9B2D-98D606BFCD1C Q37722781-60037875-88EF-448A-A12C-88EA694E280E Q37760087-E35AB0FC-F5CF-4AD1-8E83-063A53D165E3 Q37940623-BA1D3B6F-6ED5-4EDA-BE3E-BBD21429ABAC Q37955981-9B246A40-68C8-43B2-82EC-0677DFFBCD18 Q37999053-7A5EDACD-926A-42CD-87ED-81A313FD21A5 Q38031982-1DEFDF03-F4ED-4C6A-95D1-B3B3F5CCBA77 Q38136258-84BC1366-BD09-4A26-BC48-58025EAFEC86

P2860

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q46442389

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Botulinum toxin type A (BOTOX) ...... ind, placebo-controlled trial.

@en

Botulinum toxin type A (BOTOX) ...... ind, placebo-controlled trial.

@nl

type

label

Botulinum toxin type A (BOTOX) ...... ind, placebo-controlled trial.

@en

Botulinum toxin type A (BOTOX) ...... ind, placebo-controlled trial.

@nl

prefLabel

Botulinum toxin type A (BOTOX) ...... ind, placebo-controlled trial.

@en

Botulinum toxin type A (BOTOX) ...... ind, placebo-controlled trial.

@nl

P1433

Q46442389-A71A4008-3B90-408D-86D1-F5152D03FB00

P1476

Q46442389-3132F6FC-87E6-4651-8BF5-F0F9908C5F90

P2093

Q46442389-5E649D06-42C5-4361-A672-D4FF9768E96C

Q46442389-5ED65F6E-885B-49F7-923E-A81FFB4EAB58

Q46442389-8C0752C4-8E68-4B61-928A-2761894EF03B

Q46442389-A11FC278-E1BC-49EC-9C8D-484E4E364244

Q46442389-CE099958-74AA-4ABC-B170-B92FE613EBB4

Q46442389-F5FC4777-1584-4B09-937D-D478D8F36E5E

Q46442389-F8B7E5B7-2EF0-423A-AA86-F98245331F38

P2860

Q46442389-0135B091-9034-4406-92C5-9544C8B9946A

Q46442389-0875C845-C93D-4A7B-836E-02A3C64871CE

Q46442389-19686B95-2450-440B-8738-306900D85853

Q46442389-1B46FD57-4A6E-4772-AD32-CCBE547D9DBE

Q46442389-3F418534-908A-4A0C-AE6B-B7D1F09E48CE

Q46442389-4C8EFA65-FE2D-489A-9BEB-662B7D3D123E

Q46442389-4FC03C62-B89B-435F-8F27-D6670E388D3C

Q46442389-5601BA24-D84F-40D7-8498-C080A93F2ADC

Q46442389-5C1F289C-74A8-4B45-8B4C-7FE403E8B900

Q46442389-5FB24430-F2A9-4A13-98A6-91782F5DF842

P304

Q46442389-3C1B5912-6A17-4C74-A4EB-7CCB6BC9252E

P31

Q46442389-6B2E2051-96D6-4251-814A-B8AE4A20E97B

P356

Q46442389-DBD7D83F-DA65-469C-B45E-3F47B4CB0453

P433

Q46442389-E0F4BCDF-08EA-4052-A4E9-FA3D1EA0DB70

P478

Q46442389-556757A9-0925-43DA-8163-D78382519589

P577

Q46442389-E9F9AA72-5235-435B-9E5A-E2F97367D628

P698

Q46442389-7D7D9C23-CBEB-439E-8CD3-8A3EDDF51241

P921

Q46442389-71C1610B-8C45-4F54-BBC7-0F8C57225CF4

Q46442389-DC1FA58D-80E9-4220-AA25-AE492A2465FE

P356

J.1526-4610.2005.05066.X

P1433

P1476

Botulinum toxin type A (BOTOX) ...... ind, placebo-controlled trial.

@en

P2093

BOTOX CDH Study Group

http://www.w3.org/2001/XMLSchema#string

Benjamin M Frishberg

http://www.w3.org/2001/XMLSchema#string

Catherine Turkel

http://www.w3.org/2001/XMLSchema#string

John Gibson

http://www.w3.org/2001/XMLSchema#string

Marek Gawel

http://www.w3.org/2001/XMLSchema#string

Ninan T Mathew

http://www.w3.org/2001/XMLSchema#string

Rozalina Dimitrova

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

Incidence and predictors for chronicity of headache in patients with episodic migraine

Prophylactic pharmacological treatment of chronic daily headache.

Chronic daily headache.

Procedures for administering botulinum toxin type A for migraine and tension-type headache.

Migraine prophylaxis with divalproex.

Chronic daily headache: nosology and pathophysiology.

Migraine: preventive treatment.

Evidence for antinociceptive activity of botulinum toxin type A in pain management.

Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.

P304

293-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1526-4610.2005.05066.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15836565

http://www.w3.org/2001/XMLSchema#string

P921